• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / HPV / Cervarix / Sólo seis de cada cien niñas de 14 años se vacunaron del papiloma en 2010

Sólo seis de cada cien niñas de 14 años se vacunaron del papiloma en 2010

January 18, 2011 By Jonathan Leave a Comment

La vacuna que protege del cáncer de cuello de útero y que Salud pone gratis desde 2008 no logra convencer a los padres · Las inmunizaciones han caído un 88%

Granadahoy.com

GRANADA | Updated 17.01.2011 – 01:00

(Google Translation)

The first shot of Granada was the September 15, 2008 at the health center of La Caleta. Salud included in the autumn of 2008 the vaccine human papillomavirus (HPV), which protects against cervical cancer or cervical cancer in the childhood vaccination schedule to administer free girls of 14 years. A fact that following the recommendations of the experts called for these girls to be vaccinated to immunize against the virus and prevent infection is acquired during sex.

The first year of implementation the boom to vaccinate girls and get protection against the virus that causes this type of cancer led to the vaccination to 58% of girls candidates to do so, they met 14 years in 2008, more than ,600 in the province.

But stay away from that level of vaccination, which is voluntary and therefore can not impose Health, the numbers are dropping dramatically and now, three years after its implementation, the application of these vaccines is becoming almost testimonial.

According to data provided from the Office of Health, in 2010, when they were vaccinated about 4,725 calls to girls born in 1996, only 320 completed all three doses of vaccine. That is, only 6.8% of girls likely to be vaccinated against papilloma virus last year did so for three doses, which ensure their protection. However, the first dose was received 989, the second 774 and the third the 320 mentioned above.

For the year 2008, the decline in vaccinations has been brutal as they have been inoculated with 88.1% fewer girls than the first year of implementation of the vaccine. In 2009, 1,460 completed the three doses of the 4,778 candidates girls.

The decline may have several explanations: Parents do not want to vaccinate their daughters to doubt the efficacy of the vaccine at home is preferred to explain to the girls the importance of condom use to prevent this and other sexually transmitted diseases or the appearance side effects in some cases increases the rejection of the dose.

______________________________________________________

Salud incluyó en otoño de 2008 la vacuna del virus del papiloma humano (VPH), la que protege del cáncer de cérvix o cuello de útero, en el calendario vacunal infantil para administrarla gratuitamente a las niñas de 14 años. Un hecho que siguiendo las recomendaciones de los expertos instaba a estas niñas a vacunarse para inmunizarse contra el virus y prevenir esta enfermedad, que se adquiere en las relaciones sexuales.

El primer año de su implantación el boom por vacunar a las niñas y conseguir una protección frente al virus que causa este tipo de cáncer hizo que se vacunara un 58% de las niñas candidatas a hacerlo, las que cumplían 14 años en 2008, más de 4.600 en la provincia.

Pero lejos de mantenerse ese nivel de vacunación, que es voluntaria y por tanto Salud no puede imponerla, las cifras están bajando notablemente y hoy en día, tres años después de su implantación, la solicitud de estas vacunas se está volviendo casi testimonial.

Según los datos facilitados desde la Delegación de Salud, en 2010, cuando estaban llamadas a vacunarse unas 4.725 niñas nacidas en 1996, sólo 320 completaron las tres dosis de la vacuna. Es decir, sólo el 6,8% de las niñas susceptibles de vacunarse contra el virus del papiloma el año pasado lo hicieron con las tres dosis correspondientes, las que aseguran su protección. Con todo, la primera dosis la recibieron 989, la segunda 774 y la tercera las 320 antes mencionadas.

Respecto al año 2008, el descenso de las vacunaciones ha sido brutal ya que se han inoculado un 88,1% menos de niñas que el primer año de implantación de la vacuna. En 2009 completaron las tres dosis 1.460 niñas de las 4.778 candidatas.

El descenso podría tener varias explicaciones: Los padres no quieren vacunar a sus hijas por dudar de la eficacia de la vacuna, en casa se prefiere explicar a las niñas la importancia del uso del preservativo para prevenir esta y otras enfermedades de transmisión sexual o la aparición de efectos secundarios en algunos casos aumenta el rechazo a la dosis.

Read Full Article…

Related

Filed Under: Cervarix, Cervical Cancer, Gardasil / Silgard Tagged With: Anal Cancer, Autoimmune Diseases, cervarix, Cervical Cancer HPV, Gardasil/Silgard, GlaxoSmithKline, Merck, STD's, vaccinations, Vaccine Adverse Reactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Kristin from Newcastle

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

the canary party

Gardasil: I am not a coincidence

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in